Part 1: Diagnosis and Treatment of Anxiety  and Depressive Disorders for the Primary Care and Mental Health Clinician

Anxiety and Depressive Disorders are commonly seen and treated by primary care and mental health clinicians. This presentation will focus on: office diagnosis of anxiety spectrum and depressive disorders with emphasis on psychopharmacological treatments; the interaction between medical illness and inflammation and stress; and polypharmacy risks and benefits.

Part 2: ADHD Across the Life Cycle

ADHD is a genetic brain difference that exists in many people from the very young to the very old. It becomes a problem when it is severe enough to interfere with normal functioning. We see intellectual, behavior and social problems that can be a result of attention difficulties. This lecture will enable the doctor and or health care providers to make an effective diagnosis of ADHD and prescribe a treatment plan that will include appropriate medications, social support and life style changes. 

Learning Objectives

Part 1: Diagnosis and Treatment of Anxiety  and Depressive Disorders for the Primary Care and Mental Health Clinician

  • Review the symptoms and effective treatment of anxiety and depression in office evaluation.
  • Discuss the role of medical illness, inflammation, and stress and their relationship to anxiety and depressive disorders.
  • Evaluate the therapeutic role of polypharmacy as well as its potential hazards of drug interactions in the treatment of anxiety and depression disorders.

Part 2: ADHD Across the Life Cycle

  • Review the clinical path to generate the diagnosis of ADHD.
  • Summarize the neurobiology of ADHD to the patient and family.
  • Apply strategies to choose the proper medication for ADHD.
  • Outline approaches to enable the patient to develop life style changes and structural strategies to manage his/her ADHD

Faculty Disclosures

Carl Salzman, MD

No relevant relationships to disclose

John J. Ratey, MD

No relevant relationships to disclose 

Russell G. Vasile, MD

No relevant relationships to disclose 

Fine Print

Internet Explorer (version 9.0 and above) is the minimum supported browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, DBC Pri-Med, LLC, or Vindico Medical Education.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

pmiCME Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. pmiCME, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. pmiCME is the accredited provider for this activity.

Disclosures and Conflict of Interest
pmiCME requires all individuals in a position to influence educational content for pmiCME-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. pmiCME assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation. pmiCME and Vindico Medical Education staff have no relevant financial relationships to disclose.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by pmiCME or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email or call (877) 477-4633.

pmiCME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of pmiCME to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.